Search Results - "Kaminsky, Marie Christine"

Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010–02) by Racadot, Séverine, Thennevet, Isabelle, Ouldbey, Yaelle, Kaminsky, Marie-Christine, Bosset, Mathieu, Martin, Laurent, Tao, Yungan, Sire, Christian, de Raucourt, Dominique, Alfonsi, Marc, Malaurie, Emmanuelle, Tourani, Jean-Marc, Fournel, Pierre, Vauleon, Elodie, Modesto, Anouchka, Rolland, Frédéric, Metzger, Séverine, Pommier, Pascal, Chabaud, Sylvie, Dussart, Sophie

“…We investigated the efficacy and safety of afatinib maintenance therapy in patients with head and neck squamous cell carcinoma (HNSCC) with macroscopically…”
Get full text

Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01 by MACHIELS, Jean-Pascal H, HENRY, Stéphanie, MOXHON, Anne, DUPREZ, Thierry, GUIGAY, Joel, ZANETTA, Sylvie, KAMINSKY, Marie-Christine, MICHOUX, Nicolas, ROMMEL, Denis, SCHMITZ, Sandra, BOMPAS, Emmanuelle, DILLIES, Anne-Françoise, FAIVRE, Sandrine

“…PURPOSE To assess the efficacy and toxicity of sunitinib monotherapy in palliative squamous cell carcinoma of the head and neck (SCCHN). PATIENTS AND METHODS…”
Get full text

Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial by Aparicio, Thomas, Bennouna, Jaafar, Le Malicot, Karine, Boige, Valérie, Taieb, Julien, Bouché, Olivier, Phelip, Jean-Marc, François, Eric, Borel, Christian, Faroux, Roger, Dahan, Laetitia, Bachet, Jean-Baptiste, Egreteau, Joelle, Kaminsky, Marie-Christine, Gornet, Jean-Marc, Cojocarasu, Oana, Gasmi, Mohamed, Guerin-Meyer, Véronique, Lepage, Côme, Ghiringhelli, François

“…Background Identifying patients with metastatic colorectal cancer who will have an early disease progression during induction chemotherapy (IC) and identifying…”
Get full text

Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients by Berton, Dominique, Floquet, Anne, Lescaut, Willy, Baron, Gabriel, Kaminsky, Marie-Christine, Toussaint, Philippe, Largillier, Rémy, Savoye, Aude-Marie, Alexandre, Jérôme, Delbaldo, Catherine, Malaurie, Emmanuelle, Barletta, Hugues, Bosacki, Claire, Garnier-Tixidre, Claire, Follana, Philippe, Laharie-Mineur, Hortense, Briac Levache, Charles, Valenza, Bruno, Dechartres, Agnès, Mollon-Grange, Delphine, Selle, Frédéric

“…Introduction: Bevacizumab-containing therapy is considered a standard-of-care front-line option for stage IIIB–IV ovarian cancer based on results of randomized…”
Get full text

Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer by Uwer, Lionel, Rotonda, Christine, Guillemin, Francis, Miny, Joëlle, Kaminsky, Marie-Christine, Mercier, Mariette, Tournier-Rangeard, Laetitia, Leonard, Isabelle, Montcuquet, Philippe, Rauch, Philippe, Conroy, Thierry

“…The aim of this study was to compare the responsiveness of the European Organization for Research and Treatment (EORTC) quality of life questionnaires…”
Get full text

Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma by Kim, Stefano, Meurisse, Aurélia, Spehner, Laurie, Stouvenot, Morgane, François, Eric, Buecher, Bruno, André, Thierry, Samalin, Emmanuelle, Jary, Marine, Nguyen, Thierry, El Hajbi, Farid, Baba-Hamed, Nabil, Pernot, Simon, Kaminsky, Marie-Christine, Bouché, Olivier, Desrame, Jerome, Zoubir, Mustapha, Ghiringhelli, François, Parzy, Aurélie, de la Fouchardiere, Christelle, Boulbair, Fatiha, Lakkis, Zaher, Klajer, Elodie, Jacquin, Marion, Taieb, Julien, Vendrely, Véronique, Vernerey, Dewi, Borg, Christophe

“…Aims: The addition of docetaxel to cisplatin and 5-fluorouracil (DCF) has shown promising efficacy in advanced squamous cell carcinoma of the anus (SCCA)…”
Get full text

Need for Neck Dissection After Radiochemotherapy? A Study of the French GETTEC Group by Vedrine, Pierre-Olivier, Thariat, Juliette, Hitier, Martin, Janot, François, Kaminsky, Marie-Christine, Makeieff, Marc, De Raucourt, Dominique, Lapeyre, Michel, Toussaint, Bruno

“…Background/Hypothesis: The need for a neck dissection after radiochemotherapy (RCT) for patients with unresectable cancer of the head and neck remains…”
Get full text

Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01) by CULINE, Stéphane, LORTHOLARY, Alain, DOUILLARD, Jean-Yves, MERROUCHE, Yacine, ALLOUACHE, Jelila, GOUPIL, Alain, NEGRIER, Sylvie, VIALA, Juliette, PETROW, Peter, BOUZY, Jeannine, LAPLANCHE, Agnès, FIZAZI, Karim, VOIGT, Jean-Jacques, BUGAT, Roland, THEODORE, Christine, PRIOU, Frank, KAMINSKY, Marie-Christine, LESIMPLE, Thierry, PIVOT, Xavier, COUDERT, Bruno

“…To evaluate the efficacy and toxicity of novel chemotherapy combinations including cisplatin with gemcitabine (GC) or irinotecan (IC) for patients with…”
Get full text

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study by Sun, Xu-Shan, Tao, Yungan, Le Tourneau, Christophe, Pointreau, Yoann, Sire, Christian, Kaminsky, Marie-Christine, Coutte, Alexandre, Alfonsi, Marc, Boisselier, Pierre, Martin, Laurent, Miroir, Jessica, Ramee, Jean-Francois, Delord, Jean-Pierre, Clatot, Florian, Rolland, Frederic, Villa, Julie, Magne, Nicolas, Elicin, Olgun, Gherga, Elisabeta, Nguyen, France, Lafond, Cedrick, Bera, Guillaume, Calugaru, Valentin, Geoffrois, Lionnel, Chauffert, Bruno, Zubel, Angela, Zanna, Claudio, Brienza, Silvano, Crompton, Philippa, Rouits, Elisabeth, Gollmer, Kathrin, Szyldergemajn, Sergio, Bourhis, Jean

“…Debio 1143 is an orally available antagonist of inhibitor of apoptosis proteins with the potential to enhance the antitumour activity of cisplatin and…”
Get full text

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial by Geoffrois, Lionnel, Martin, Laurent, De Raucourt, Dominique, Sun, Xu Shan, Tao, Yungan, Maingon, Philippe, Buffet, Joëlle, Pointreau, Yoann, Sire, Christian, Tuchais, Claude, Babin, Emmanuel, Coutte, Alexandre, Rolland, Frédéric, Kaminsky, Marie-Christine, Alfonsi, Marc, Lapeyre, Michel, Saliou, Marie, Lafond, Cédric, Jadaud, Eric, Gery, Bernard, Zawadi, Ayman, Tourani, Jean-Marc, Khoury, Cédric, Henry, Anne Rose, Hasbini, Ali, Guichard, François, Borel, Christian, Meert, Nicolas, Guillet, Pierre, Calais, Marie-Hélène, Garaud, Pascal, Bourhis, Jean

“…Both concurrent chemoradiotherapy (CT-RT) and cetuximab radiotherapy (cetux-RT) have been established as the standard of care for the treatment of locally…”
Get full text

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study by Kim, Stefano, François, Eric, André, Thierry, Samalin, Emmanuelle, Jary, Marine, El Hajbi, Farid, Baba-Hamed, Nabil, Pernot, Simon, Kaminsky, Marie-Christine, Bouché, Olivier, Desrame, Jérôme, Zoubir, Mustapha, Ghiringhelli, François, Parzy, Aurélie, De La Fouchardiere, Christelle, Smith, Denis, Deberne, Mélanie, Spehner, Laurie, Badet, Nicolas, Adotevi, Olivier, Anota, Amélie, Meurisse, Aurélia, Vernerey, Dewi, Taieb, Julien, Vendrely, Véronique, Buecher, Bruno, Borg, Christophe

“…The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades. Currently, there is no validated treatment for…”
Get full text

False positive results can occur on delayed reading of intradermal tests with cisplatin by Guyot-Caquelin, Pauline, MD, Granel, Florence, MD, Kaminsky, Marie-Christine, MD, Trechot, Philippe, PharmD, Schmutz, Jean-Luc, MD, Barbaud, Annick, MD, PhD

“…Whereas IDTs with PS have a good negative predictive value,1,4 especially in immediate reactions to PS, in delayed skin reactions occurring with…”
Get full text

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial by Tao, Yungan, Auperin, Anne, Sire, Christian, Martin, Laurent, Khoury, Cedric, Maingon, Philippe, Bardet, Etienne, Kaminsky, Marie-Christine, Lapeyre, Michel, Chatellier, Thierry, Alfonsi, Marc, Pointreau, Yoann, Jadaud, Eric, Géry, Bernard, Zawadi, Ayman, Tourani, Jean-Marc, Laguerre, Brigitte, Coutte, Alexandre, Racadot, Séverine, Hasbini, Ali, Malaurie, Emanuelle, Borel, Christian, Meert, Nicolas, Cornely, Alexandre, Ollivier, Nathalie, Casiraghi, Odile, Sun, Xu Shan, Bourhis, Jean

“…Purpose To investigate the effect of adding concurrent chemotherapy (CT) to cetuximab plus radiotherapy (RT; CT-cetux-RT) compared with cetuximab plus RT…”
Get full text

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial by Galot, Rachel, Le Tourneau, Christophe, Saada-Bouzid, Esma, Daste, Amaury, Even, Caroline, Debruyne, Philip, Henry, Stéphanie, Zanetta, Sylvie, Rutten, Anemie, Licitra, Lisa, Canon, Jean-Luc, Kaminsky, Marie-Christine, Specenier, Pol, Rottey, Sylvie, Guigay, Joël, Kong, Anthony, Tinhofer, Inge, Borcoman, Edith, Dirix, Lieve, Raveloarivahy, Tiana, Fortpied, Catherine, Vanlancker, Maureen, Morfouace, Marie, Govaerts, Anne-Sophie, Machiels, Jean-Pascal

“…Monalizumab is a monoclonal antibody targeting the inhibitory natural killer group 2A (NKG2A) receptor localised on natural killer (NK) and T cells. Its…”
Get full text

A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer by Blanc-Durand, Félix, Yaniz-Galende, Elisa, Llop-Guevara, Alba, Genestie, Catherine, Serra, Violeta, Herencia-Ropero, Andrea, Klein, Christophe, Berton, Dominique, Lortholary, Alain, Dohollou, Nadine, Desauw, Christophe, Fabbro, Michel, Malaurie, Emmanuelle, Bonichon-Lamaichhane, Nathalie, Dubot, Coraline, Kurtz, Jean Emmanuel, de Rauglaudre, Gaëtan, Raban, Nadia, Chevalier-Place, Annick, Ferron, Gwenael, Kaminsky, Marie-Christine, Kramer, Claire, Rouleau, Etienne, Leary, Alexandra

“…Homologous recombination deficiency (HRD), defined as BRCA1/2 mutation (BRCAmut) or high genomic instability, is used to identify ovarian cancer (OC) patients…”
Get full text

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial by TAO, Yungan, Sun, Xu-Shan, Pointreau, Yoann, Le Tourneau, Christophe, Sire, Christian, Kaminsky, Marie-Christine, Coutte, Alexandre, Alfonsi, Marc, Calderon, Benôit, Boisselier, Pierre, Martin, Laurent, Miroir, Jessica, Ramee, Jean-Francois, Delord, Jean-Pierre, Clatot, Florian, Rolland, Frederic, Villa, Julie, Magne, Nicolas, Elicin, Olgun, Gherga, Elisabeta, Nguyen, France, Lafond, Cédrik, Bera, Guillaume, Calugaru, Valentin, Geoffrois, Lionnel, Chauffert, Bruno, Damstrup, Lars, Crompton, Philippa, Ennaji, Abdallah, Gollmer, Kathrin, Nauwelaerts, Heidi, Bourhis, Jean

“…We report long-term efficacy and overall survival (OS) results from a randomised, double-blind, phase 2 study (NCT02022098) investigating xevinapant plus…”
Get full text

A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX by Boisselier, Pierre, Kaminsky, Marie-Christine, Thézenas, Simon, Gallocher, Olivier, Lavau-Denes, Sandrine, Garcia-Ramirez, Muriel, Alfonsi, Marc, Cupissol, Didier, de Forges, Hélène, Janiszewski, Chloé, Geoffrois, Lionnel, Sire, Christian, Senesse, Pierre

“…In a previous phase II study an immunonutrient supplement was found to reduce severe acute toxicities for head and neck squamous cell cancer (HNSCC) patients…”
Get full text

Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy by Lee, Chee Khoon, Asher, Rebecca, Friedlander, Michael, Gebski, Val, Gonzalez-Martin, Antonio, Lortholary, Alain, Lesoin, Anne, Kurzeder, Christian, Largillier, Remy, Hilpert, Felix, Hardy-Bessard, Anne-Claire, Kaminsky, Marie-Christine, Poveda, Andres, Pujade-Lauraine, Eric

“…Platinum-resistant ovarian cancer (PROC) is associated with a variable prognosis and unpredictable survival times. We have developed and validated a prognostic…”
Get full text

Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial by Ferron, Gwénaël, De Rauglaudre, Gaëtan, Becourt, Stéphanie, Delanoy, Nicolas, Joly, Florence, Lortholary, Alain, You, Benoît, Bouchaert, Patrick, Malaurie, Emmanuelle, Gouy, Sebastien, Kaminsky, Marie-Christine, Meunier, Jérôme, Alexandre, Jérôme, Berton, Dominique, Dohollou, Nadine, Dubot, Coraline, Floquet, Anne, Favier, Laure, Venat-Bouvet, Laurence, Fabbro, Michel, Louvet, Christophe, Lotz, Jean-Pierre, Abadie-Lacourtoisie, Sophie, Desauw, Christophe, Del Piano, Francesco, Leheurteur, Marianne, Bonichon-Lamichhane, Nathalie, Rastkhah, Mansour, Follana, Philippe, Gantzer, Justine, Ray-Coquard, Isabelle, Pujade-Lauraine, Eric

“…The oral anti-angiogenic therapy nintedanib prolongs progression-free survival (PFS) when combined with chemotherapy after primary surgery for advanced…”
Get full text

Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study) by Robelin, Patrick, Tod, Michel, Colomban, Olivier, Lachuer, Joel, Ray-Coquard, Isabelle, Rauglaudre, Gaëtan De, Joly, Florence, Chevalier-Place, Annick, Combe, Pierre, Lortholary, Alain, Hamizi, Salima, Raban, Nadia, Ferron, Gwénaël, Meunier, Jérôme, Berton-Rigaud, Dominique, Alexandre, Jérôme, Kaminsky, Marie-Christine, Dubot, Coraline, Leary, Alexandra, Malaurie, Emmanuelle, You, Benoit

“…MicroRNAs (miRNAs) are promising biomarkers in ovarian cancer. Their kinetics during treatment might be useful for monitoring disease burden, and guiding…”
Get full text